JP2023509798A5 - - Google Patents
Info
- Publication number
- JP2023509798A5 JP2023509798A5 JP2022542380A JP2022542380A JP2023509798A5 JP 2023509798 A5 JP2023509798 A5 JP 2023509798A5 JP 2022542380 A JP2022542380 A JP 2022542380A JP 2022542380 A JP2022542380 A JP 2022542380A JP 2023509798 A5 JP2023509798 A5 JP 2023509798A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062959977P | 2020-01-12 | 2020-01-12 | |
| US62/959,977 | 2020-01-12 | ||
| PCT/US2021/013112 WO2021142477A1 (en) | 2020-01-12 | 2021-01-12 | Neuroactive steroids and pharmaceutical composition containing the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023509798A JP2023509798A (ja) | 2023-03-09 |
| JP2023509798A5 true JP2023509798A5 (https=) | 2024-01-19 |
| JPWO2021142477A5 JPWO2021142477A5 (https=) | 2024-01-19 |
Family
ID=76788885
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022542380A Pending JP2023509798A (ja) | 2020-01-12 | 2021-01-12 | ニューロアクティブステロイド、及びニューロアクティブステロイドを含む医薬組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230118577A1 (https=) |
| EP (1) | EP4087854A4 (https=) |
| JP (1) | JP2023509798A (https=) |
| KR (1) | KR20230031812A (https=) |
| CN (1) | CN115244065B (https=) |
| AU (1) | AU2021206712A1 (https=) |
| BR (1) | BR112022013585A2 (https=) |
| CA (1) | CA3167331A1 (https=) |
| IL (1) | IL294606A (https=) |
| MX (1) | MX2022008614A (https=) |
| WO (1) | WO2021142477A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202112111WA (en) | 2019-05-10 | 2021-11-29 | Brii Biosciences Inc | Pharmaceutical composition containing brexanolone, ganaxolone, or zuranolone, and use thereof |
| CR20240234A (es) * | 2019-05-31 | 2024-07-09 | Sage Therapeutics Inc | ESTEROIDES NEUROACTIVOS Y COMPOSICIONES DE ESTOS (Divisional 2021-629) |
| TW202143976A (zh) * | 2020-03-18 | 2021-12-01 | 美商賽吉醫療公司 | 神經活性類固醇及其使用方法 |
| CN115974950A (zh) * | 2022-12-23 | 2023-04-18 | 上海彩迩文生化科技有限公司 | 一种3-烷基化的甾体中间体及其制备和应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1359646A (fr) * | 1962-11-22 | 1964-04-30 | Roussel Uclaf | Procédé de préparation de dérivés stéroïdes et produits obtenus par ce procédé |
| NL6808141A (https=) * | 1967-06-16 | 1968-12-17 | ||
| GB1409239A (en) * | 1971-11-11 | 1975-10-08 | Glaxo Lab Ltd | Process for the preparation of 3alpha-hydroxy-5alpha-steroids |
| HK1258616A1 (zh) * | 2016-03-08 | 2019-11-15 | Sage Therapeutics, Inc. | 神经活性类固醇、组合物、及其用途 |
| MA45599A (fr) * | 2016-07-11 | 2019-05-15 | Sage Therapeutics Inc | Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation |
| CR20240234A (es) * | 2019-05-31 | 2024-07-09 | Sage Therapeutics Inc | ESTEROIDES NEUROACTIVOS Y COMPOSICIONES DE ESTOS (Divisional 2021-629) |
| MX2022010620A (es) * | 2020-02-27 | 2022-11-30 | Brii Biosciences Inc | Profarmacos de esteroides neuroactivos. |
-
2021
- 2021-01-12 WO PCT/US2021/013112 patent/WO2021142477A1/en not_active Ceased
- 2021-01-12 CA CA3167331A patent/CA3167331A1/en active Pending
- 2021-01-12 US US17/792,319 patent/US20230118577A1/en not_active Abandoned
- 2021-01-12 JP JP2022542380A patent/JP2023509798A/ja active Pending
- 2021-01-12 EP EP21738878.4A patent/EP4087854A4/en active Pending
- 2021-01-12 KR KR1020227027899A patent/KR20230031812A/ko active Pending
- 2021-01-12 IL IL294606A patent/IL294606A/en unknown
- 2021-01-12 BR BR112022013585A patent/BR112022013585A2/pt unknown
- 2021-01-12 AU AU2021206712A patent/AU2021206712A1/en active Pending
- 2021-01-12 MX MX2022008614A patent/MX2022008614A/es unknown
- 2021-01-12 CN CN202180020110.2A patent/CN115244065B/zh active Active